Gefitinib (250mg).

Jun 13, 2023

Gefitinib (250mg)
GEFISTERIS is a medication used for the treatment of non-small cell lung cancer (NSCLC). GEFISTERIS belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). GEFISTERIS works by inhibiting the activity of epidermal growth factor receptor (EGFR), which is often overexpressed in certain types of cancer cells, including NSCLC.
By blocking EGFR, GEFISTERIS helps to slow down or stop the growth of cancer cells, thereby reducing the size of tumors. It is specifically used for the treatment of NSCLC in patients who have mutations in the EGFR gene.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now: https://www.sterisonline.com/product/gefisteris-250-133658

SHARE WITH